Jagsonpal Pharmaceuticals Ltd vs Sat Kartar Shopping Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Jagsonpal Pharmaceuticals Ltd is ₹ 200.15 as of 18 May 15:30 . The P/E Ratio of Jagsonpal Pharmaceuticals Ltd changed from 12.2 on March 2021 to 25.9 on March 2025 . This represents a CAGR of 16.25% over 5 yearsThe P/E Ratio of Sat Kartar Shopping Ltd changed from 24.4 on March 2025 to 24.4 on March 2025 . This represents a CAGR of 0.00% over 1 years The Market Cap of Jagsonpal Pharmaceuticals Ltd changed from ₹ 208.41 crore on March 2021 to ₹ 1433 crore on March 2025 . This represents a CAGR of 47.06% over 5 yearsThe Market Cap of Sat Kartar Shopping Ltd changed from ₹ 239.4 crore on March 2025 to ₹ 239.4 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Jagsonpal Pharmaceuticals Ltd for the Mar '26 is ₹ 67.37 crore as compare to the Dec '25 revenue of ₹ 75.92 crore. This represent the decline of -11.26% The revenue of Sat Kartar Shopping Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Jagsonpal Pharmaceuticals Ltd for the Mar '26 is ₹ 14.33 crore as compare to the Dec '25 ebitda of ₹ 17.16 crore. This represent the decline of -16.49% The ebitda of Sat Kartar Shopping Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Jagsonpal Pharmaceuticals Ltd changed from ₹ 5.33 crore to ₹ 8.76 crore over 8 quarters. This represents a CAGR of 28.20% The net profit of Sat Kartar Shopping Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Jagsonpal Pharmaceuticals Ltd changed from 15.36 % on March 2021 to 29.99 % on March 2025 . This represents a CAGR of 14.32% over 5 yearsThe Dividend Payout of Sat Kartar Shopping Ltd changed from 3.11 % on March 2024 to 11.22 % on March 2025 . This represents a CAGR of 89.94% over 2 years .

About Jagsonpal Pharmaceuticals Ltd

Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana.
The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs.
Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India.
It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.
In 1994, the company has also promoted Aresco Financial Services, a new financial company.

About Sat Kartar Shopping Ltd

Sat Kartar Shopping Limited was incorporated as a Private Limited Company with the name of 'Sat Kartar Shopping Private Limited' vide Certificate of Incorporation dated June 29, 2012, issued by Registrar of Companies, Delhi.
Further, Company converted into a Public Limited Company & name of the Company was changed to Sat Kartar Shopping Limited & Registrar of Companies, Delhi has issued a New Certificate of Incorporation consequent upon conversion dated July 12, 2021.
Manprit Singh Chadha is the Promoter of the Company. Sat Kartar Shopping is an Ayurveda healthcare company committed to providing natural wellness solutions relating to specific therapeutic areas and general lifestyle products, committed to promote a healthier lifestyle.
It integrate traditional Ayurvedic knowledge with modern research to empower individuals to adopt healthier lifestyles.

FAQs for the comparison of Jagsonpal Pharmaceuticals Ltd and Sat Kartar Shopping Ltd

Which company has a larger market capitalization, Jagsonpal Pharmaceuticals Ltd or Sat Kartar Shopping Ltd?

Market cap of Jagsonpal Pharmaceuticals Ltd is 1,343 Cr while Market cap of Sat Kartar Shopping Ltd is 293 Cr

What are the key factors driving the stock performance of Jagsonpal Pharmaceuticals Ltd and Sat Kartar Shopping Ltd?

The stock performance of Jagsonpal Pharmaceuticals Ltd and Sat Kartar Shopping Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jagsonpal Pharmaceuticals Ltd and Sat Kartar Shopping Ltd?

As of May 18, 2026, the Jagsonpal Pharmaceuticals Ltd stock price is INR ₹200.15. On the other hand, Sat Kartar Shopping Ltd stock price is INR ₹186.1.

How do dividend payouts of Jagsonpal Pharmaceuticals Ltd and Sat Kartar Shopping Ltd compare?

To compare the dividend payouts of Jagsonpal Pharmaceuticals Ltd and Sat Kartar Shopping Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.